Partillion Updates
Partillion Technology in the News - How Can we Improve Cell Therapies? (Copy)
GEN Interviews Partillion Co-Founder, Prof. Dino Di Carlo, on Latest Advancements in Functional Single-Cell Assays and their Implications for Developing Therapies.
Tracking Transcripts in Biologics and Cell Therapies
In an interview with Genetic Engineering & Biotechnology News Partillion Bioscience Co-Founder and Prof of Bioengineering at UCLA, Dino Di Carlo highlights how single-cell tools such as our nanovial technology play a critical role in improving cell therapies by enabling functional screening of cells.